Table 3.

Factors Influencing the Initial and Trajectory of 25-Item National Eye Institute Visual Functioning Questionnaire Composite Scores during the First 3 Years of Follow-up for 125 Individuals Assigned to Undergo Systemic Therapy in the Multicenter Steroid Treatment Trial and Follow-up Study

Characteristic	No. (%) at Randomization	25-Item National Eye Institute Visual Functioning Questionnaire Score at Randomization: Estimated Mean Difference at Randomization in Points (95% Confidence Interval)*	P Value
Visual acuity worse than 20/40	34 (27)	−17.61 (−25.05 to −10.16)	<0.001
Visual field impairment
Moderate (−3 to −6 dB)	33 (26)	−10.26 (−17.06 to −3.46)	0.003
Severe (<−6 dB)	37 (30)	−12.68 (−19.93 to −5.43)	<0.001
Male	26 (21)	2.35 (−4.03 to 8.74)	0.47
Black	31 (25)	2.40 (−4.61 to 9.41)	0.50
For each 10 yrs older than 45 years at randomization	125 (100)	0.20 (−1.51 to 1.91)	0.82
Posterior uveitis or panuveitis	78 (62)	−1.72 (−7.52 to 4.08)	0.56
	No. (%) at Follow-up Visits	Change in 25-Item National Eye Institute Visual Functioning Questionnaire Scores from Randomization to Follow-up: Estimated Mean Difference from Randomization to Follow-up in Points (95% Confidence Interval)*
For every additional 6 mos from randomization	660 (100)	1.58 (1.05–2.12)	<0.001

Visual acuity and visual field impairment were assessed in the better-seeing eye.

^*Adjusted for all factors simultaneously.